Financials
Financial year 2025
Dokriphar from Gent, company number BE0541871001, closed financial year 2025 with a result of € 91,699 after tax. For that financial year Dokriphar recorded a gross margin of € 170,911 and equity of € 2.8 million. Compared with financial year 2024, the result moved from € 136,259 to € 91,699. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 30, 2026.
€ 2.8 million
▲ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 91,699
▼ 33% vs 2024
Profit after tax over the fiscal year.
€ 332,927
▲ 127% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 77,495 paid out
85 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 258
▼ 5% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 14,665
▲ 11% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 10,158
▲ 155% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 16,784
▼ 46% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 151,950 | € 183,344 | € 239,709 | € 170,911 | ▼ 29% |
| Profit after taxes | € 63,309 | € 90,197 | € 136,259 | € 91,699 | ▼ 33% |
| Equity | € 2,638,569 | € 2,728,765 | € 2,815,236 | € 2,829,439 | ▲ 1% |
| Total debts | € 47,107 | € 36,707 | € 39,173 | € 27,837 | ▼ 29% |
| Cash | € 138,370 | € 503,409 | € 146,939 | € 332,927 | ▲ 127% |
| Land & buildings | € 273,157 | € 241,393 | € 209,630 | € 177,999 | ▼ 15% |
| Retained profit | € 938,569 | € 1,028,765 | € 1,115,236 | € 1,129,439 | ▲ 1% |
| Dividend | € 0 | € 0 | € 49,789 | € 77,495 | ▲ 56% |
| Balance sheet total | € 2,685,675 | € 2,765,473 | € 2,854,408 | € 2,857,276 |
Key figures of Dokriphar, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to Dokriphar?
What happened at Dokriphar in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 91,699 (▼ 33% vs 2024). Source: NBB ↗
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 63,309 profit in 2022 to € 91,699 profit in 2025.
Paid € 166,543 in corporate taxes since 2022.
Best year ever: 2024, with € 136,259 profit.
Paid out € 127,284 in dividends to the owners in total.
Management
Behind Dokriphar are Kristof Casteur and Dominiek Simoens. It owns 99% of Cassipharma BV itself.
Directors
According to the 2025 annual accounts
Kristof Casteur
Director
Dominiek Simoens
Director
Establishments
Establishment units
Physical locations of this company
Oudenaardegoed 14
9031 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0541.871.001
- VAT number
- BE 0541.871.001
- Registered office
- Oudenaardegoed 14, 9031 Gent
- Names & denominations
- Dokriphar
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 November 2013
- Peppol
- Active · Active since 6 Oct 2025
- Activities · NACE
Activiteiten van holdings
Holdings
Overige zakelijke dienstverlening, neg
Handel in eigen onroerend goed